AEON Biopharma, Inc. (AEON)

AEON Biopharma Statistics

Total Valuation

AEON Biopharma has a market cap or net worth of $26.43 million. The enterprise value is $37.07 million.

Market Cap	26.43M
Enterprise Value	37.07M

Important Dates

The next estimated earnings date is Monday, March 23, 2026, after market close.

Earnings Date	Mar 23, 2026
Ex-Dividend Date	n/a

Share Statistics

AEON Biopharma has 24.02 million shares outstanding. The number of shares has decreased by -91.04% in one year.

Current Share Class	24.02M
Shares Outstanding	24.02M
Shares Change (YoY)	-91.04%
Shares Change (QoQ)	+4.91%
Owned by Insiders (%)	14.26%
Owned by Institutions (%)	7.01%
Float	8.54M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.90

Current Ratio	0.90
Quick Ratio	0.72
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-165.52%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-3,333.40%
Weighted Average Cost of Capital (WACC)	4.72%
Revenue Per Employee	n/a
Profits Per Employee	-$600
Employee Count	5
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -87.32% in the last 52 weeks. The beta is 0.72, so AEON Biopharma's price volatility has been lower than the market average.

Beta (5Y)	0.72
52-Week Price Change	-87.32%
50-Day Moving Average	1.03
200-Day Moving Average	0.83
Relative Strength Index (RSI)	48.36
Average Volume (20 Days)	241,191

Short Selling Information

The latest short interest is 37,337, so 0.16% of the outstanding shares have been sold short.

Short Interest	37,337
Short Previous Month	114,239
Short % of Shares Out	0.16%
Short % of Float	0.44%
Short Ratio (days to cover)	0.11

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-16.87M
Pretax Income	-3,000
Net Income	-3,000
EBITDA	-16.79M
EBIT	-16.87M
Earnings Per Share (EPS)	-$0.00

Balance Sheet

The company has $5.93 million in cash and $18.26 million in debt, with a net cash position of -$12.33 million or -$0.51 per share.

Cash & Cash Equivalents	5.93M
Total Debt	18.26M
Net Cash	-12.33M
Net Cash Per Share	-$0.51
Equity (Book Value)	-19.87M
Book Value Per Share	-1.71
Working Capital	-816,000

Cash Flow

In the last 12 months, operating cash flow was -$13.22 million and capital expenditures -$4,000, giving a free cash flow of -$13.22 million.

Operating Cash Flow	-13.22M
Capital Expenditures	-4,000
Free Cash Flow	-13.22M
FCF Per Share	-$0.55

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

AEON Biopharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	91.04%
Shareholder Yield	91.04%
Earnings Yield	-0.01%
FCF Yield	-53.43%

Analyst Forecast

The average price target for AEON Biopharma is $7.20, which is 554.55% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$7.20
Price Target Difference	554.55%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on February 26, 2025. It was a reverse split with a ratio of 1:72.

Last Split Date	Feb 26, 2025
Split Type	Reverse
Split Ratio	1:72

Scores

Altman Z-Score	n/a
Piotroski F-Score	1